Form 4: Coeptis Therapeutics Holdings CFO Reports Stock Transaction
Insider Transaction (Form 4)
Brian Cogley, Chief Financial Officer of Coeptis Therapeutics Holdings, Inc., reported multiple transactions in common stock on July 27, 2026.
Summary
- Option exercise/conversion: acquired 4,112 Common Stock on July 27, 2026; holds 26,612 after (Direct).
- Option exercise/conversion: disposed of 4,112 Restricted Stock Units on July 27, 2026; holds 12,335 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Brian Cogley — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Option exercise/conversion | Common Stock | 4,112 | — | — | 26,612 |
| 2026-07-27 | Option exercise/conversion | Restricted Stock Units | 4,112 | — | — | 12,335 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Option exercise/conversion (4,112 shares) |
| 2026-07-27 | Option exercise/conversion (4,112 shares) |
Keywords
insider transaction, Form 4, ZSQR, Z Squared Inc., neutral, Brian Cogley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.